August 7th 2024
Why is it important for organizations to set long-term goals when planning for a sustainable future?
July 24th 2024
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
July 17th 2024
How teamwork among safety-net healthcare providers and pharma can make the difference.
June 7th 2024
Causal mediation analysis sought to determine how public hesitancy plays a role in the government procurement of certain vaccines.
May 30th 2024
These advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
Manufacturers: Get ready for global trade account management
Partnering to diversify yields rapid growth
A family-owned pharmaceutical manufacturer plots a 21st-century growth plan
Drug pricing debate is sharpening
Will formularies become a consumer's concern for healthcare provision?
Managing third-party risks in the life sciences industry
Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners
The Price of Global Health
Defining 'market access'
A brightening outlook for pharma
The Impending AMP Rule, still waiting three years later
Some state-level changes give an indication of what to prepare for
Economic and clinical value: the future of cancer care
An 'expectations convergence' is building in how drug efficacy aligns with patient outcomes
Legal uncertainties in the DSCSA
The Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification
Is tech running you? Four ways to retake control
Modern training technologies make the prospect of days-long training courses an obsolete practice
Converging the pharma business with its logistics and data functions
Pharma in China--calculated risk gone wrong
Doing business in China is undergoing important changes
Industry should reinforce cargo security practices with TAPA participation
Ultimately, supply chain integrity should include both temperature control and security against theft or diversion
Merger mania does not equal a downward spiral in pharma employment
Managing quality risks across the pharmaceutical supply chain
Well designed quality systems follow the product life cycle and foster a culture of quality
The importance of accreditation for specialty pharmacy organizations
Why accreditation?
Commerce and clinical research: where the twain meet
The pharma rep profession will be immortal
New reasons why the announced death of this profession will always be premature
Six factors driving new specialty pharmacies
What you need to know about the current specialty pharmacy landscape
Common misconceptions about the orphan drug designation
Things to know about the increasingly popular--and competitive--orphan drug space
Top health industry issues for life sciences in 2014
PwC's annual forecast of the year's most important healthcare trends
Networking for life science logistics
The Health & Personal Care Logistics Conference brings industry leaders together
DQSA: a bargain for the life sciences industry
The Drug Quality and Security Act will change industry for the better
DME competitive bidding issues: When is enough enough?
Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)
The best 'good guys' in pharma distribution
Recent US Supreme Court decisions narrow life-sciences patentability claims
Industry response may be to keep more innovations as trade secrets
Getting to the 'hub' of the matter
The perfect pharmaceutical product would be a pill or injection that, once taken, has a near-immediate beneficial effect.
Supreme Court: reverse payment settlements subject to antitrust scrutiny
What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?
Worldwide, pharma distribution is moving to a serial-coded basis
Regardless of how pending US legislation is resolved, manufacturers need to move ahead
Medical Affairs' changing role in market access and reimbursement